E2F transcription factors regulate genes involved in cell-cycle progression. In mammalian cells, physiological E2F exists as an E2F/DP heterodimer. Currently, eight E2F and two DP subunits have been characterized. We report here the characterization of a new member of the DP family, DP-4. While DP-4 exhibits certain similarities with members of the DP family, it also possesses a number of significant differences. Thus, DP-4 forms a heterodimer with E2F subunits, binds to the E2F site and associates with pocket proteins including pRb. In contrast to DP-1, however, DP-4/E2F-1 complexes exhibit reduced DNA binding activity. Furthermore, DP-4 interferes with E2F-1-dependent transcription and delays cell-cycle progression. These results highlight an emerging complexity in the DP family of E2F subunits, and suggest that DP-4 may endow E2F heterodimers with distinct transcription properties.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/sj.onc.1209343 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Inhibition of KPNA2 by ivermectin reduces E2F1 nuclear translocation to attenuate keratinocyte proliferation and ameliorate psoriasis-like lesions.
Int Immunopharmacol
December 2024
State Key Laboratory of Analytical Chemistry for Life Science & Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing 210093, PR China. Electronic address:
Article Synopsis
- * Using ivermectin, which inhibits KPNA2, significantly improved psoriasis symptoms in mice by reducing redness, scaling, and thickness of the skin, alongside lower levels of KPNA2 and markers of skin cell growth.
- * The research also showed that reducing KPNA2 affected key signaling pathways in skin cells, suggesting it plays a crucial role in the development of psoriasis and could be a viable target for new treatments in the future.
BET degrader exhibits lower antiproliferative activity than its inhibitor via EGR1 recruiting septins to promote E2F1-3 transcription in triple-negative breast cancer.
Pharmacol Res
October 2024
Department of Infectious Diseases and Center of Infectious Diseases and Pathogen Biology, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, The First Hospital of Jilin University, Changchun 130061, China. Electronic address:
The bromodomain and extraterminal domain (BET) family proteins serve as primary readers of acetylated lysine residues and play crucial roles in cell proliferation and differentiation. Dysregulation of BET proteins has been implicated in tumorigenesis, making them important therapeutic targets. BET-bromodomain (BD) inhibitors and BET-targeting degraders have been developed to inhibit BET proteins.
View Article and Find Full Text PDFThe SAGA acetyltransferase module is required for the maintenance of MAF and MYC oncogenic gene expression programs in multiple myeloma.
Genes Dev
September 2024
Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas 77054, USA;
Article Synopsis
- - Despite advancements in treatment, multiple myeloma (MM) is still an incurable cancer, with gaps in understanding the epigenetic mechanisms that contribute to its development and progression.
- - The study focuses on the SAGA complex, particularly the ADA2B subunit, which plays a critical role in regulating key pathways like MTORC1 signaling and oncogenic programs associated with transcription factors MYC, E2F, and MAF.
- - The research reveals that targeting SAGA's KAT module and its interaction with specific acetyltransferases could present new therapeutic vulnerabilities in MM, potentially leading to future treatment strategies.
Mathematical Models Including microRNA Levels of Mesenteric Adipose Tissue May Predict Postoperative Relapse in Crohn's Disease Patients.
Gastro Hep Adv
September 2023
Inflammatory Bowel Diseases Research Laboratory, Gastrocenter, Colorectal Surgery Unit, Surgery Department, School of Medical Sciences, University of Campinas (Unicamp), Campinas, São Paulo, Brazil.
Article Synopsis
- Recent research indicates that mesenteric adipose tissue (MAT) may influence the development and progression of Crohn's disease (CD) by altering specific microRNA (miRNA) levels and their target genes.
- In a study involving surgical specimens from 25 active CD patients and 15 control patients, significant upregulation of miRNA-650 and miRNA-29c was observed in the MAT of CD patients, alongside decreased expression of their respective target genes.
- Our findings identified a mathematical model with 100% accuracy for predicting the recurrence of CD, highlighting the potential role of miRNAs in patient outcomes following surgery.
Small Nuclear Ribonucleoprotein Polypeptides B and B1 Promote Osteosarcoma Progression via Activating the Ataxia-Telangiectasia Mutated Signaling Pathway through Ribonucleotide Reductase Subunit M2.
Am J Pathol
November 2024
Spinal Tumor Center, Department of Orthopedic Oncology, The Second Affiliated Hospital of Naval Medical University, Shanghai, China. Electronic address:
Osteosarcoma is a malignant bone tumor characterized by high metastatic potential and recurrence rates after therapy. The small nuclear ribonucleoprotein polypeptides B and B1 (SNRPB), core components of a spliceosome, exhibit up-regulation across several cancer types. However, the precise role of SNRPB in osteosarcoma progression remains poorly elucidated.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!